RET Inhibitors in Non-Small-Cell Lung Cancer

SIMPLE SUMMARY: Non-small cell lung cancer (NSCLC) remains a significant cause of death worldwide, despite the significant progresses to date. Multiple molecular alterations have been identified in NSCLC, leading to the development of target-based agents that have shown significant clinical benefits...

Descripción completa

Detalles Bibliográficos
Autores principales: Cascetta, Priscilla, Sforza, Vincenzo, Manzo, Anna, Carillio, Guido, Palumbo, Giuliano, Esposito, Giovanna, Montanino, Agnese, Costanzo, Raffaele, Sandomenico, Claudia, De Cecio, Rossella, Piccirillo, Maria Carmela, La Manna, Carmine, Totaro, Giuseppe, Muto, Paolo, Picone, Carmine, Bianco, Roberto, Normanno, Nicola, Morabito, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431193/
https://www.ncbi.nlm.nih.gov/pubmed/34503226
http://dx.doi.org/10.3390/cancers13174415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431193/
https://www.ncbi.nlm.nih.gov/pubmed/34503226
http://dx.doi.org/10.3390/cancers13174415

Ejemplares similares